Call with Prithvi Nair
Maya · Solvance Pharma · Jun 30, 2026 • 9:21 AM
Transcript
Analysis readyMaya0:00
Hi Prithvi, this is Maya from Freyr Solutions — I'm reaching out about Regulatory Affairs for Solvance Pharma. Did I catch you at an okay moment?
Prithvi0:45
Sure, I've got a minute. What's this about exactly?
Maya1:30
In short, we take the routine regulatory load off your team so they can focus on strategy — former FDA and EMA reviewers, 5,000+ submissions delivered. Where does regulatory affairs sit on your priority list right now?
Prithvi2:14
That's relevant — we're scoping this for next quarter. Can you send something over and circle back?
Maya2:59
Absolutely. I'll email a short overview of Regulatory Affairs today and follow up next week. Who else should I include?
Prithvi3:44
Just me for now, thanks.
Prithvi Nair
Director, Regulatory Ops
Solvance Pharma
Call details
What happened
Interested but timing-dependent — Prithvi asked Maya to send details on Regulatory Affairs and follow up after their internal review. A callback is owed.
Call analysis
NeutralOverall sentiment
Neutral
Talk ratio
73% agent
Objections
0
Turns
6
Sentiment through the call
How the mood moved, turn by turn — higher is warmer.
Turn-by-turn heat map
Who did the talking
Share of words spoken — aim for a balanced discovery call.
Conversation participation
How often each person took a turn in the discussion.
Objections raised
What Prithvi pushed back on — handle these next time.
No clear objections — a smooth conversation.
Call timeline
The shape of the conversation.
Opening
0:00
Discovery
0:45
Wrap-up
3:44